These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 1097479)

  • 1. Crossover clinical trial of benapryzine and trihexyphenidyl in Parkinsonian patients.
    Lamid S; Jenkins RB
    J Clin Pharmacol; 1975; 15(8-9):622-6. PubMed ID: 1097479
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Some initial animal and human pharmacological studies with benapryzine (BRL 1288).
    Brown DM; Hughes BO; Marsden CD; Meadows JC; Spicer B
    Br J Pharmacol; 1973 Mar; 47(3):476-86. PubMed ID: 4581246
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Benapryzine for parkinsonism.
    Drug Ther Bull; 1974 Aug; 12(17):67-8. PubMed ID: 4616812
    [No Abstract]   [Full Text] [Related]  

  • 4. [Therapeutic effects of L-dopa and trihexyphenidyl in Parkinson's disease--an examination by a double blind method].
    Hirayama K; Uono M; Nakanishi T; Kato N; Nagao Y
    Shinkei Kenkyu No Shimpo; 1971; 15(1):267-85. PubMed ID: 4937721
    [No Abstract]   [Full Text] [Related]  

  • 5. Parkinson's disease and myasthenia gravis: adverse effect of trihexyphenidyl on neuromuscular transmission.
    Ueno S; Takahashi M; Kajiyama K; Okahisa N; Hazama T; Yorifuji S; Tarui S
    Neurology; 1987 May; 37(5):832-3. PubMed ID: 3033545
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Orobuccal dyskinesia associated with trihexyphenidyl therapy in a patient with Parkinson's disease.
    Hauser RA; Olanow CW
    Mov Disord; 1993 Oct; 8(4):512-4. PubMed ID: 8232363
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A controlled study comparing trihexyphenidyl hydrochloride plus levodopa with placebo plus levodopa in patients with Parkinson's disease.
    Martin WE; Loewenson RB; Resch JA; Baker AB
    Neurology; 1974 Oct; 24(10):912-9. PubMed ID: 4606107
    [No Abstract]   [Full Text] [Related]  

  • 8. 3-O-Methyldopa, L-dopa, and trihexyphenidyl in the treatment of Parkinson's disease.
    Muenter MD; Dinapoli RP; Sharpless NS; Tyce GM
    Mayo Clin Proc; 1973 Mar; 48(3):173-83. PubMed ID: 4570387
    [No Abstract]   [Full Text] [Related]  

  • 9. A double-blind comparison of the efficacy of EX 10-029 and trihexyphenidyl hydrochloride in relieving drug-induced Parkinsonian symptoms.
    Freeman H; Mehta IS
    Curr Ther Res Clin Exp; 1972 Aug; 14(8):470-7. PubMed ID: 4629309
    [No Abstract]   [Full Text] [Related]  

  • 10. Comparative trial of benzhexol, amantadine, and levodopa in the treatment of Parkinson's disease.
    Parkes JD; Baxter RC; Marsden CD; Rees JE
    J Neurol Neurosurg Psychiatry; 1974 Apr; 37(4):422-6. PubMed ID: 4838913
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Disturbance of recent memory function in parkinsonian patients on anticholinergic therapy.
    Koller WC
    Cortex; 1984 Jun; 20(2):307-11. PubMed ID: 6744901
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of trihexyphenidyl, an anticholinergic agent, on regional cerebral blood flow and oxygen metabolism in patients with Parkinson's disease.
    Takahashi S; Tohgi H; Yonezawa H; Obara S; Yamazaki E
    J Neurol Sci; 1999 Aug; 167(1):56-61. PubMed ID: 10500263
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Mental confusion during the treatment of Parkinson disease with trihexyphenidyl].
    Graux P; Durocher AM; Copin JM
    Lille Med; 1980; 25(6):271-2. PubMed ID: 7401896
    [No Abstract]   [Full Text] [Related]  

  • 14. [Tactile hallucinations induced by trihexyphenidyl in a patient with Parkinson's disease].
    Funakawa I; Jinnai K
    Rinsho Shinkeigaku; 2005 Feb; 45(2):125-7. PubMed ID: 15782612
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Trihexyphenidyl induced malignant hyperthermia in a patient with Parkinson's disease complicated with pneumonia: A case report.
    Zhao J; Xu G; Feng C; Chen Y; Kang Y; Liu F; Ma W
    Medicine (Baltimore); 2020 May; 99(20):e20129. PubMed ID: 32443324
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of benapryzine in psychotic patients treated with phenothiazines.
    Bartlett P; Forrest A
    Curr Med Res Opin; 1974; 2(6):313-8. PubMed ID: 4155663
    [No Abstract]   [Full Text] [Related]  

  • 17. Combination therapy of extrapyramidal disease with trihexyphenidyl and L-dopa: an electromyographic study with specific reference to tremor.
    Hökendorf H
    J Int Med Res; 1979; 7(1):19-28. PubMed ID: 421963
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacologic treatment of parkinsonian tremor.
    Koller WC
    Arch Neurol; 1986 Feb; 43(2):126-7. PubMed ID: 3947248
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anticholinergic withdrawal and benzhexol treatment in Parkinson's disease.
    Horrocks PM; Vicary DJ; Rees JE; Parkes JD; Marsden CD
    J Neurol Neurosurg Psychiatry; 1973 Dec; 36(6):936-41. PubMed ID: 4772727
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effects of anti-Parkinson drugs on cortical neurones.
    Clarke G; Davies J
    Br J Pharmacol; 1973 Mar; 47(3):465-75. PubMed ID: 4730827
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.